MOH
- Status: likely_approved
🇮🇱 Molecule 129 in Israel
Molecule 129 (TAGRAXOFUSP) regulatory status in Israel.
Marketing authorisations
MOH
- Status: likely_approved
Molecule 129 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Molecule 129 approved in Israel?
Yes. MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Molecule 129 in Israel?
Stemline Therapeeutics Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.